BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24211727)

  • 41. Prediction of postoperative survival by preoperative serum concentrations of anti-p53 compared to CEA, CA 50, CA 242 and conventional blood tests in patients with colorectal carcinoma.
    Forslund A; Engarås B; Lönnroth C; Lundholm K
    Int J Oncol; 2002 May; 20(5):1013-8. PubMed ID: 11956598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytokeratin serum biomarkers in patients with colorectal cancer.
    Holdenrieder S; Stieber P; Liska V; Treska V; Topolcan O; Dreslerova J; Matejka VM; Finek J; Holubec L
    Anticancer Res; 2012 May; 32(5):1971-6. PubMed ID: 22593474
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
    Kawamura M; Toiyama Y; Tanaka K; Saigusa S; Okugawa Y; Hiro J; Uchida K; Mohri Y; Inoue Y; Kusunoki M
    Eur J Cancer; 2012 Sep; 48(14):2244-51. PubMed ID: 22197219
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of relationship between serum vascular adhesion protein-1 (VAP-1) and gestational diabetes mellitus.
    Dincgez Cakmak B; Dundar B; Ketenci Gencer F; Yildiz DE; Bayram F; Ozgen G; Aydin Boyama B
    Biomarkers; 2019 Dec; 24(8):750-756. PubMed ID: 31638437
    [No Abstract]   [Full Text] [Related]  

  • 45. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum matrilysin levels predict outcome in curatively resected colorectal cancer patients.
    Martínez-Fernandez A; García-Albeniz X; Pineda E; Visa L; Gallego R; Codony-Servat J; Augé JM; Longarón R; Gascón P; Lacy A; Castells A; Maurel J
    Ann Surg Oncol; 2009 May; 16(5):1412-20. PubMed ID: 19259740
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Survival of elderly persons undergoing colonoscopy: implications for colorectal cancer screening and surveillance.
    Kahi CJ; Azzouz F; Juliar BE; Imperiale TF
    Gastrointest Endosc; 2007 Sep; 66(3):544-50. PubMed ID: 17725944
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human vascular adhesion proteın-1 (VAP-1): serum levels for hepatocellular carcinoma in non-alcoholic and alcoholic fatty liver disease.
    Kemik O; Sümer A; Kemik AS; Itik V; Dulger AC; Purisa S; Tuzun S
    World J Surg Oncol; 2010 Sep; 8():83. PubMed ID: 20849600
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic significance of preoperative serum CA 19.9 assay in patients with colorectal carcinoma.
    Diez M; Cerdán FJ; Pollán M; Maestro ML; Ortega MD; Martínez S; Moreno G; Balibrea JL
    Anticancer Res; 1994; 14(6B):2819-25. PubMed ID: 7872725
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level.
    Park IJ; Choi GS; Lim KH; Kang BM; Jun SH
    Ann Surg Oncol; 2009 Nov; 16(11):3087-93. PubMed ID: 19629600
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum sE-selectin levels and carcinoembryonic antigen mRNA-expressing cells in peripheral blood as prognostic factors in colorectal cancer patients.
    Ferroni P; Roselli M; Spila A; D'Alessandro R; Portarena I; Mariotti S; Palmirotta R; Buonomo O; Petrella G; Guadagni F
    Cancer; 2010 Jun; 116(12):2913-21. PubMed ID: 20336782
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preoperative carcinoembryonic antigen elevation in colorectal cancer.
    Yeh CY; Hsieh PS; Chiang JM; Lai CC; Chen JS; Wang JY; Hung HY
    Hepatogastroenterology; 2011; 58(109):1171-6. PubMed ID: 21937372
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema: part 2.
    Inoue T; Morita M; Tojo T; Nagashima A; Moritomo A; Imai K; Miyake H
    Bioorg Med Chem; 2013 May; 21(9):2478-94. PubMed ID: 23540955
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elevation of platelet count in patients with colorectal cancer predicts tendency to metastases and poor prognosis.
    Lin MS; Huang JX; Zhu J; Shen HZ
    Hepatogastroenterology; 2012 Sep; 59(118):1687-90. PubMed ID: 22591645
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Semicarbazide sensitive amine oxidase overexpression has dual consequences: insulin mimicry and diabetes-like complications.
    Stolen CM; Madanat R; Marti L; Kari S; Yegutkin GG; Sariola H; Zorzano A; Jalkanen S
    FASEB J; 2004 Apr; 18(6):702-4. PubMed ID: 14977883
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection.
    Tsai HL; Chu KS; Huang YH; Su YC; Wu JY; Kuo CH; Chen CW; Wang JY
    J Surg Oncol; 2009 Dec; 100(8):736-43. PubMed ID: 19757443
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Macrophage inflammatory protein-3 alpha (MIP-3a) is a novel serum prognostic marker in patients with colorectal cancer.
    Iwata T; Tanaka K; Inoue Y; Toiyama Y; Hiro J; Fujikawa H; Okugawa Y; Uchida K; Mohri Y; Kusunoki M
    J Surg Oncol; 2013 Feb; 107(2):160-6. PubMed ID: 22926691
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort.
    Dehal AN; Newton CC; Jacobs EJ; Patel AV; Gapstur SM; Campbell PT
    J Clin Oncol; 2012 Jan; 30(1):53-9. PubMed ID: 22124092
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients.
    Matsushita K; Toiyama Y; Tanaka K; Saigusa S; Hiro J; Uchida K; Inoue Y; Kusunoki M
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S518-27. PubMed ID: 21845497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.